{
  "docId": "019de070-a5cb-72a4-ac7d-0f26e10cd805",
  "docSlug": "05d98084f9bd31c78a17b84718191aae",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 39,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 15,
  "notes": "The slide uses a stacked bar chart to show revenue trends over time, split by China and EMs ex China.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a5cb-72a4-ac7d-0f26e10cd805/18",
  "deckHref": "/decks/019de070-a5cb-72a4-ac7d-0f26e10cd805",
  "deckJsonHref": "/decks/019de070-a5cb-72a4-ac7d-0f26e10cd805.json",
  "deckAnchorHref": "/decks/019de070-a5cb-72a4-ac7d-0f26e10cd805#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.46,
        "x": 0.51,
        "y": 0.79
      },
      "kind": "callout",
      "text": "Revenue anticipated to continue growing ahead of the long-term ambition of mid to high single-digit growth",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97f6aa2d-1ab1-4972-99df-0d2c0d8f1f00",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.32,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Revenue trends for China and EMs ex China from Q1 2018 to Q4 2020",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50bfdd35-57bd-41a8-9d42-7a48398cae7b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.52,
        "y": 0.22
      },
      "kind": "list",
      "text": "Performance driven by new medicines +59% (33% of total revenue; $1.1bn incrementally)\nOncology +36%: Tagrisso ($1.2bn); March 2021 NRDL inclusion\nNew CVRM +31%: Forxiga (+55%); Brilinta (+4%)\nRespiratory & Immunology -18%: Pulmicort COVID-19 hit ($798m, -33%), but Symbicort continued up ($567m, +9%)\nDiversified growth: AP +6%, MEA +1%, LA +13%, Russia +4%\nMajor 2020 NRDL inclusions: Lynparza, Forxiga, roxadustat\nMajor 2020 VBP inclusions: Brilinta, legacy GI medicines",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e37c033-7cbb-4c83-afa0-b66e52cb3c99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.46,
        "x": 0.51,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Total revenue at actual exchange rates; changes at CER and for FY 2020, unless stated otherwise. 1. Total revenue at CER 2. Asia Pacific 3. Middle East, Africa and other 4. Latin America 5. Gastrointestinal; Losec, Nexium.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20ccc7bd-4b9f-4961-b04f-9c02f1bef39a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Emerging markets\nDiverse and solid growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00f09589-85ec-4514-bd57-edf7732d6973",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "28aefe5a-28d1-434a-9f31-ea6da08d94d5",
      "evidence": "The slide mentions 'Revenue anticipated to continue growing ahead of the long-term ambition of mid to high single-digit growth' and shows a chart/bar-stacked which could indicate a waterfall chart.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 18,
      "from": 13,
      "beatId": "f46a0338-6851-4c4f-8928-0fddd4ceb387",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document provides satisfaction with strong growth and pipeline progress",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}